Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05561738 · ClinicalTrials.gov registry record · NA

Nicotinamide Riboside in Ulcerative Colitis

A NA study of Ulcerative Colitis, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05561738 is a NA study of Ulcerative Colitis that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 40 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05561738, a NA study of Ulcerative Colitis, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double-blind pilot study of Nicotinamide Riboside (NR) in Pediatric-onset Ulcerative Colitis (UC).

Conditions Studied

Ulcerative Colitis

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • OTHER Standard of Care
  • DIETARY_SUPPLEMENT Nicotinamide Riboside Chloride

Study Locations (1)

Pennsylvania

  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-28
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05561738

The ClinicalTrials.gov registry entry for NCT05561738 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05561738 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05561738 about?

NCT05561738 is a clinical study titled "Nicotinamide Riboside in Ulcerative Colitis". This is a randomized, double-blind pilot study of Nicotinamide Riboside (NR) in Pediatric-onset Ulcerative Colitis (UC).

What is the current status of trial NCT05561738?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-28. Estimated completion is 2026-06-30.

What conditions does trial NCT05561738 study?

This clinical trial studies the following conditions: Ulcerative Colitis.

What interventions are being tested in trial NCT05561738?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Standard of Care (OTHER), Nicotinamide Riboside Chloride (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05561738?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05561738 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.